Greens:
Greens: Science, innovation, and global reach in therapies
Who We Are
Greens: Greens: Science, innovation, and global reach in therapies
Who We AreWe are global leaders in the herbal pharmaceutical industry. With operations in the United States and Switzerland, and strategic partnerships worldwide, we specialize in the research, development, and production of high-quality herbal medicines and plant-based pharmaceutical products.
Our portfolio ranges from herbal medicines and phytopharmaceuticals to advanced oncological formulations and next-generation psychedelic compounds such as psilocybin, all supported by rigorous scientific research and innovation in R&D (Research and Development).
With excellence as our foundation, we combine cutting-edge technology, scientific rigor, and a strong commitment to personalized and effective treatments. Our mission is to deliver therapies that transform health and well-being, with a truly global perspective and impact.

Certification and Quality
We hold Swiss GMP certification from Swissmedic, a global benchmark in pharmaceutical quality. This seal guarantees that our processes meet the highest international standards of safety and efficacy.
Each production stage is rigorously audited, ensuring consistent quality and full traceability. With Swiss GMP, we offer trust and excellence in healthcare.

Innovation: Present and Future
We invest in innovation and technology in the production of highly complex phytopharmaceuticals that are difficult to develop and produce.

Reliable Products
High-standard products aiming at access to medicines guaranteed under the regulation of international and national regulatory agencies.

Reliability
To ensure the safety, effectiveness and reliability of treatments, we use only high-purity ingredients and strictly control the manufacturing processes.
The MED line represents the most advanced in personalized medicine, featuring cannabinoids with more than 0.3% THC. Developed using pharmaceutical-grade raw materials and manufactured in Switzerland, this line offers unique formulations, carefully custom-made to meet each patient’s specific needs. With a wide range of high-concentration cannabinoids and therapeutic precision, MED medications combine technology, quality, and personalization to deliver effective, safe treatments aligned with the highest international standards.
Developed with balanced formulations of CBD and up to 0.3% THC, this line is ideal for supporting daily well-being. Indicated for managing conditions such as anxiety, insomnia, and mild pain, it offers an effective combination of safety, traceability, and pharmaceutical quality, promoting confidence and consistency in continuous use.
With a focus on cutting-edge biotechnology, the Balance line incorporates nanotechnology into its formulations, enhancing the therapeutic action of isolated, high-purity cannabinoids such as CBG, CBN, CBDA, and THCV. This nanotechnology ensures molecular precision and high bioavailability, optimizing absorption and clinical efficacy. Especially indicated for the treatment of chronic and complex diseases, the Balance line reaffirms GREENS’ position as a global leader in advanced cannabinoid-based therapies.
RESEARCH & INNOVATION (R&D)
Get your quote now
or contact us